
Pharmacally
VYVGART
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in VYVGART
Health TidingsVYVGART Opens New Doors Across MG Subtypes and Steps Earlier Into CIDPargenx reported new clinical data at AAN 2026 demonstrating that VYVGART and VYVGART Hytrulo improve outcomes across diverse myasthenia gravis populations, including antibody-negative and adolescent patients, while also…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.